We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEES
2101
DELISTED
H&E Equipment Services
HEES
$4.6M ﹤0.01%
154,418
-1,335
-0.9% -$34.4K
BOOT icon
2102
Boot Barn
BOOT
$4.95B
$4.59M ﹤0.01%
105,868
+2,873
+3% +$108K
NP
2103
DELISTED
Neenah, Inc. Common Stock
NP
$4.58M ﹤0.01%
82,830
+3,646
+5% +$167K
WNC icon
2104
Wabash National
WNC
$527M
$4.58M ﹤0.01%
265,733
-28,021
-10% -$453K
IBCP icon
2105
Independent Bank Corp
IBCP
$844M
$4.57M ﹤0.01%
247,543
-38,769
-14% -$635K
ECHO
2106
EchoStar
ECHO
$26.2B
$4.57M ﹤0.01%
215,624
-896
-0.4% -$21.4K
CENX icon
2107
Century Aluminum
CENX
$5.07B
$4.55M ﹤0.01%
412,844
+50
+0% +$453
EB
2108
DELISTED
Eventbrite
EB
$4.55M ﹤0.01%
251,370
-27,766
-10% -$389K
CNST
2109
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$4.53M ﹤0.01%
157,181
-22,194
-12% -$559K
INGN icon
2110
Inogen
INGN
$164M
$4.51M ﹤0.01%
100,832
+3,138
+3% +$108K
TRST
2111
Trustco Bank Corp NY
TRST
$938M
$4.5M ﹤0.01%
135,055
-13,234
-9% -$399K
UTL icon
2112
Unitil
UTL
$980M
$4.5M ﹤0.01%
70,608
+164
+0.2% +$6.54K
PRTA icon
2113
Prothena Corp
PRTA
$450M
$4.5M ﹤0.01%
374,250
-7,597
-2% -$89.9K
TFSL icon
2114
TFS Financial
TFSL
$4.93B
$4.49M ﹤0.01%
254,437
-23,329
-8% -$388K
TEN
2115
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$4.49M ﹤0.01%
423,027
+4,127
+1% +$39K
OSUR icon
2116
OraSure Technologies
OSUR
$279M
$4.47M ﹤0.01%
422,198
-117,056
-22% -$1.54M
IIIN icon
2117
Insteel Industries
IIIN
$625M
$4.44M ﹤0.01%
199,480
-5,037
-2% -$114K
CRVL icon
2118
CorVel
CRVL
$3.19B
$4.44M ﹤0.01%
125,625
+3,954
+3% +$123K
RCKT icon
2119
Rocket Pharmaceuticals
RCKT
$394M
$4.42M ﹤0.01%
137,840
-143,124
-51% -$5.22M
EVOP
2120
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$4.41M ﹤0.01%
163,322
-3,760
-2% -$94.4K
DCH
2121
Dauch Corp
DCH
$1.51B
$4.38M ﹤0.01%
525,360
+14,641
+3% +$110K
AGYS icon
2122
Agilysys
AGYS
$3.06B
$4.38M ﹤0.01%
114,070
-2,294
-2% -$76.3K
TGH
2123
DELISTED
Textainer Group Holdings limited
TGH
$4.37M ﹤0.01%
227,724
-442
-0.2% -$7.55K
UVSP icon
2124
Univest Financial
UVSP
$1.18B
$4.36M ﹤0.01%
211,847
+647
+0.3% +$11.6K
PETQ
2125
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$4.36M ﹤0.01%
113,382
+7,391
+7% +$229K

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.